SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation.
Liu W, You D, Lin J, Zou H, Zhang L, Luo S, Yuan Y, Wang Z, Qi J, Wang W, Ye X, Yang X, Deng Y, Teng F, Zheng X, Lin Y, Huang Z, Huang Y, Yang Z, Zhou X, Zhang Y, Chen R, Xu L, Li J, Yang W, Zhang H.
Liu W, et al. Among authors: qi j.
Cell Metab. 2024 Oct 16:S1550-4131(24)00405-4. doi: 10.1016/j.cmet.2024.10.009. Online ahead of print.
Cell Metab. 2024.
PMID: 39419036
No abstract available.